Micronuclei frequency in peripheral blood lymphocytes and cancer risk: Evidence from human studies

Mutagenesis

Volumn 26, Issue 1, 2011, Pages 93-100

  Bonassi, Stefano ^a   El Zein, Randa ^b   Bolognesi, Claudia ^c   Fenech, Michael ^d  

^a IRCCS SAN RAFFAELE PISANA   (Italy)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^c UNIVERSITY OF GENOA   (Italy)

^d CSIRO   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER INCIDENCE; CANCER RISK; CANCER SUSCEPTIBILITY; CARCINOGENESIS; HUMAN; MICRONUCLEUS; MICRONUCLEUS TEST; NEOPLASM; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL; REVIEW;

DISEASE SUSCEPTIBILITY; HUMANS; INCIDENCE; LYMPHOCYTES; MICRONUCLEI, CHROMOSOME-DEFECTIVE; MICRONUCLEUS TESTS; NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

NICOTIANA TABACUM;

EID: 78650634202     PISSN: 02678357     EISSN: 14643804     Source Type: Journal    
DOI: 10.1093/mutage/geq075     Document Type: Review

References (89)

1. Boveri, T. (1914) Zur Frage der Entstehung Maligner Tumoren. Gustav Fisher, Jena, Germany.
2. Keen-Kim, D., Nooraie, F. and Rao, P. N. (2008) Cytogenetic biomarkers for humann cancer. Front. Biosci., 13, 5928-5949.
3. Stratton, M. R., Campbell, P. J. and Futreal, P. A. (2009) The cancer genome. Nature, 458, 719-724.
4. Loeb, L. A. (2008) Cancer exhibit a mutator phenotype: clinical implications. Cancer Res., 68, 3551-3557.
5. Cazier, J. B. and Tomlinson, I. (2010) General lessons from large-scale studies to identify human cancer predisposition genes. J. Pathol., 220, 255-262.
6. Roberts, S. A., Spreadborough, A. R., Bulman, B., Barber, J. B., Evans, D. G. and Scott, D. (1999) Heritability of cellular radiosensitivity: a marker of low-penetrance predisposition genes in breast cancer? Am. J. Hum. Genet., 65, 784-794.
7. Scott, D. (2004) Chromosomal radiosensitivity and low penetrance predisposition to cancer. Cytogenet. Genome Res., 104, 365-370.
8. Norppa, H., Bonassi, S., Hansteen, I. L. et al. (2006) Chromosomal aberrations and SCEs as biomarkers of cancer risk. Mutat. Res., 600, 37-45.
9. Fenech, M., Kirsch-Volders, M. and Natarajan, A. T. (2010) Molecular mechanisms of micronucleus, nucleoplasmic bridge and nuclear bud formation in mammalian and human cells. Mutagenesis, 26, 125-132.
10. Cloos, J., Leemans, C. R., van der Sterre, M. L., Kuik, D. J., Snow, G. B. and Braakhuis, B. J. (2000) Mutagen sensitivity as a biomarker for second primary tumors after head and neck squamous cell carcinoma. Cancer Epidemiol. Biomarkers Prev., 9, 713-717.
11. Cloos, J., Reid, C. B., Snow, G. B. and Braakhuis, B. J. (1996) Mutagen sensitivity: enhanced risk assessment of squamous cell carcinoma. Eur. J. Cancer B Oral Oncol., 32B, 367-372.
12. Wu, X., Gu, J. and Spitz, M. R. (2007) Mutagen sensitivity: a genetic predisposition factor for cancer. Cancer Res., 67, 3493-3495.
13. Wu, X., Lin, J., Etzel, C. J., Dong, Q., Gorlova, O. Y., Zhang, Q., Amos, C. I. and Spitz, M. R. (2007) Interplay between mutagen sensitivity and epidemiological factors in modulating lung cancer risk. Int. J. Cancer, 120, 2687-2695.
14. Wu, X., Spitz, M. R., Amos, C. I. et al. (2007) Mutagen sensitivity has high heritability: evidence from a twin study. Cancer Res., 67, 3493-3495.
15. Iarmarcovai, G., Ceppi, M., Botta, A., Orsiere, T. and Bonassi, S. (2008) Micronuclei frequency in peripheral blood lymphocytes of cancer patients: a meta-analysis. Mutat. Res., 659, 274-283.
16. Baeyens, A., Thierens, H., Claes, K., Poppe, B., de Ridder, L. and Vral, A. (2004) Chromosomal radiosensitivity in BRCA1 and BRCA2 mutation carriers. Int. J. Radiat. Biol., 80, 745-756.
17. Ban, S., Konomi, C., Iwakawa, M. et al. (2004) Radiosensitivity of peripheral blood lymphocytes obtained from patients with cancers of the breast, head and neck or cervix as determined with a micronucleus assay. J. Radiat. Res. (Tokyo), 45, 535-541.
18. Baeyens, A., Van Den Broecke, R., Makar, A., Thierens, H., De Ridder, L. and Vral, A. (2005) Chromosomal radiosensitivity in breast cancer patients: influence of age of onset of the disease. Oncol. Rep., 13, 347-353.
19. Mozdarani, H., Mansouri, Z. and Haeri, S. A. (2005) Cytogenetic radiosensitivity of g0-lymphocytes of breast and esophageal cancer patients as determined by micronucleus assay. J. Radiat. Res. (Tokyo), 46, 111-116.
20. Varga, D., Hoegel, J., Maier, C. et al. (2006) On the difference of micronucleus frequencies in peripheral blood lymphocytes between breast cancer patients and controls. Mutagenesis, 21, 313-320.
21. Kotsopoulos, J., Chen, Z., Vallis, K. A., Poll, A., Ainsworth, P. and Narod, S. A. (2007) DNA repair capacity as a possible biomarker of breast cancer risk in female BRCA1 mutation carriers. Br. J. Cancer, 96, 118-125.
22. Aristei, C., Stracci, F., Guerrieri, P., Anselmo, P., Armellini, R., Rulli, A., Barberini, F., Latini, P. and Meneghini, A. R. (2009) Frequency of sister chromatid exchanges and micronuclei monitored over time in patients with early-stage breast cancer: results of an observational study. Cancer Genet. Cytogenet., 192, 24-29.
23. Santos, R. A., Teixeira, A. C., Mayorano, M. B., Carrara, H. A., Andrade, J. M. and Takahashi, C. S. (2010) Basal levels of DNA damage detected by micronuclei and comet assays in untreated breast cancer patients and healthy women. Clin. Exp. Med., 10, 87-92.
24. Bolognesi, C., Filiberti, R., Neri, M. et al. (2002) High frequency of micronuclei in peripheral blood lymphocytes as index of susceptibility to pleural malignant mesothelioma. Cancer Res., 62, 5418-5419.
25. Bolognesi, C., Martini, F., Tognon, M. et al. (2005) A molecular epidemiology case control study on pleural malignant mesothelioma. Cancer Epidemiol. Biomarkers Prev., 14, 1741-1746.
26. Guler, E., Orta, T., Gunebakan, S., Utkusavas, A., Kolusayin, M. O. and Ozar (2005) Can micronucleus technique predict the risk of lung cancer in smokers? Tuberk Toraks, 53, 225-230.
27. El-Zein, R. A., Schabath, M. B., Etzel, C. J., Lopez, M. S., Franklin, J. D. and Spitz, M. R. (2006) Cytokinesis-blocked micronucleus assay as a novel biomarker for lung cancer risk. Cancer Res., 66, 6449-6456.
28. Jianlin, L., Jiliang, H., Lifen, J., Wei, Z., Zhijian, C., Shijie, C. and Shijie, X. (2006) Variation of ATM protein expression in response to irradiation of lymphocytes in lung cancer patients and controls. Toxicology, 224, 138-146.
29. Karaman, A., Binici, D. N., Kalabar, M. E. and Calikusu, Z. (2008) Micronucleus analysis in patients with colorectal adenocarcinoma and colorectal polyps. Gastroenterol., 14, 6835-6839.
30. Slonina, D. and Gasinska, A. (1997) Intrinsic radiosensitivity of healthy donors and cancer patients as determined by the lymphocyte micronucleus assay. Int. J. Radiat. Biol., 72, 693-701.
31. Duffaud, F., Orsiere, T., Digue, L., Villani, P., Volot, F., Favre, R. and Botta, A. (1999) Micronucleated lymphocyte rates from head-and-neck cancer patients. Mutat. Res., 439, 259-266.
32. Venkatachalam, P., Paul, S. F., Mohankumar, M. N., Prabhu, B. K., Gajendiran, N., Kathiresan, A. and Jeevanram, R. K. (1999) Higher frequency of dicentrics and micronuclei in peripheral blood lymphocytes of cancer patients. Mutat. Res., 425, 1-8.
33. Slonina, D., Klimek, M., Szpytma, T. and Gasinska, A. (2000) Comparison of the radiosensitivity of normal-tissue cells with normal-tissue reactions after radiotherapy. Int. J. Radiat. Biol., 76, 1255-1264.
34. Elsendoorn, T. J., Weijl, N. I., Mithoe, S., Zwinderman, A. H., Van Dam, F., De Zwart, F. A., Tates, A. D. and Osanto, S. (2001) Chemotherapy-induced chromosomal damage in peripheral blood lymphocytes of cancer patients supplemented with antioxidants or placebo. Mutat. Res., 498, 145-158.
35. Jagetia, G. C., Jayakrishnan, A., Fernandes, D. and Vidyasagar, M. S. (2001) Evaluation of micronuclei frequency in the cultured peripheral blood lymphocytes of cancer patients before and after radiation treatment. Mutat. Res., 491, 9-16.
36. Baciuchka-Palmaro, M., Orsiere, T., Duffaud, F. et al. (2002) Acentromeric micronuclei are increased in peripheral blood lymphocytes of untreated cancer patients. Mutat. Res., 520, 189-198.
37. Leal-Garza, C. H., Cerda-Flores, R. M., Leal-Elizondo, E. and Cortes-Gutierrez, E. I. (2002) Micronuclei in cervical smears and peripheral blood lymphocytes from women with and without cervical uterine cancer. Mutat. Res., 515, 57-62.
38. Widel, M., Jedrus, S., Lukaszczyk, B., Raczek-Zwierzycka, K. and Swierniak, A. (2003) Radiation- induced micronucleus frequency in peripheral blood lymphocytes is correlated with normal tissue damage in patients with cervical carcinoma undergoing radiotherapy. Radiat. Res., 159, 713-721.
39. Jianlin, L., Jiliang, H., Lifen, J., Wei, Z., Baohong, W. and Hongping, D. (2004) Measuring the genetic damage in cancer patients during radiotherapy with three genetic endpoints. Mutagenesis, 19, 457-464.
40. Minicucci, E. M., Kowalski, L. P., Maia, M. A., Pereira, A., Ribeiro, L. R., de Camargo, J. L. and Salvadori, D. M. (2005) Cytogenetic damage in circulating lymphocytes and buccal mucosa cells of head-and-neck cancer patients undergoing radiotherapy. J. Radiat. Res. (Tokyo), 46, 135-142.
41. Yildirim, I. H., Yesilada, E. and Yologlu, S. (2006) Micronucleus frequency in peripheral blood lymphocytes and exfoliated buccal cells of untreated cancer patients. Genetika, 42, 705-710.
42. Milesovic-Djordievic, O., Grjicic, D., Vaskovic, Z. and Marimkovic, D. (2010) High micronucleus frequency in peripheral blood lymphocytes of untreated cancer patients irrespective of gender, smoking and cancer sites. Tohoku J. Exp. Med., 220, 115-120.
43. Mavaddat, N., Antoniou, A. C, Easton, D. F. and Garcia-Cloasa, M. (2010) Genetic susceptibility to breast cancer. Mol. Oncol, 4, 174-191.
44. Rothfuss, A., Schutz, P., Bochum, S., Volm, T., Eberhardt, E., Kreienberg, R., Vogel, W. and Speit, G. (2000) Induced micronucleus frequencies in peripheral lymphocytes as a screening test for carriers of a BRCA1 mutation in breast cancer families. Cancer Res., 60, 390-394.
45. Trenz, K., Lugowski, S., Jahrsdorfer, U., Jainta, S., Vogel, W. and Speit, G. (2003) Enhanced sensitivity of peripheral blood lymphocytes from women carrying a BRCA1 mutation towards the mutagenic effects of various cytostatics. Mutat Res., 544, 279-288.
46. Spitz, M. R., Wei, Q., Dong, Q., Amos, C. I. and Wu, X. (2003) Genetic susceptibility to lung cancer: the role of DNA damage and repair. Cancer Epidemiol. Biomarkers Prev., 12, 689-698. (Pubitemid 36993157)
47. Hoffmann, D., Hoffmann, I. and El Bayoumy, K. (2001) Less harmeful cigarette: a controversial issue. A tribute to Ernst L. Wynder. Chem. Res. Toxicol., 14, 767-790.
48. Thun, M. J., Lally, C. A. and Flannery, J. T., Jr. (1997) Cigarette smoking and changes in the histopathology of lung cancer. J. Natl Cancer Inst., 89, 1580-1586.
49. Hecht, S. S. and Hoffmann, D. (1989) The relevance of tobacco specific nitrosamines to human cancer. Cancer Surv., 8, 273-294.
50. Adams, J. D., O'Mara-Adams and Hoffmann, D. (1987) Toxic and carcinogenic agents in undiluted mainstream smoke and side-stream smoke of different types of cigarettes. Carcinogenesis, 8, 729-731.
51. Hecht, S. S. (1999) Tobacco smoke carcinogens and lung cancer. J. Natl Cancer Inst., 91, 1194-1210.
52. Hill, C. E., Affatato, A. A., Wolfe, K. J. et al. (2005) Gender differences in genetic damage induced by the tobacco-specific nitrosamine NNK and the influence on the Thr241Met polymorphism in the XRCC3 gene. Environ. Mol. Mutagen., 4, 22-29.
53. Affatato, A. A., Wolfe, K. J., Lopez, M. S., Hallberg, C, Ammenheuser, M. M. and Abdel-Rahman, S. Z. (2004) Effect of XPD/ ERCC2 polymorphisms on chromosome aberration frequencies in smokers and on sensitivity to the mutagenic tobacco-specific nitrosamine NNK. Environ. Mol. Mutagen., 44, 65-73.
54. Abdel-Rahman, S. Z., Salama, S. A., Au, W. W. and Hamada, F. A. (2000) Role of polymorphic CYP2E1 and CYP2D6 genes in NNK-induced chromosome aberrations in cultured human lymphocytes. Pharmacogenetics, 10, 239-249.
55. Padma, P. R., Amonkar, A. J. and Bhide, S. V. (1989) Mutagenic and cytogenetic studies of N'-nitrosonornicotine and 4-(methylnitrosamino)-1-(3- pyridyl)-1-butanone. Cancer Lett., 46, 173-180.
56. Weitberg, A. B. and Corvese, D. (1993) Oxygen radicals potentiate the genetic toxicity of tobacco-specific nitrosamines. Clin. Genet., 43, 88-91.
57. Berwick, M. and Vineis, P. (2000) Markers of DNA repair and susceptibility to cancer in humans: an epidemiologic review. J. Natl Cancer Inst., 92, 874-897.
58. Hecht, S. S. (1999) DNA adduct formation from tobacco-specific N-nitrosamines. Mutat. Res., 424, 127-142.
59. Kaina, B. (1998) Critical steps in alkylation-induced aberration formation. Mutat Res., 404, 119-124.
60. Kaina, B., Ziouta, A., Ochs, K. and Coqurell, T. (1997) Chromosomal instability, reproductive cell death and apoptosis induced by O6-methylguanine in Mex-, Mex+ and methylation-tolerant mismatch repair compromised cells: facts and models. Mutat. Res., 381, 227-241.
61. Kaina, B. (2004) Mechanisms and consequences of methylating agent-induced SCEs and chromosomal aberrations: a long road traveled and still a far way to go. Cytogenet. Genome Res., 104, 77-86.
62. Hecht, S. S. (2002) Human urinary carcinogen metabolites: biomarkers for investigating tobacco and cancer. Carcinogenesis, 23, 907-1292.
63. Cloutier, J. F., Drouin, R., Weinfeld, M., O'Connor, T. R. and Castonguay, A. (2001) Characterization and mapping of DNA damage induced by reactive metabolites of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) at nucleotide resolution in human genomic DNA. J. Mol. Biol., 313, 539-557.
64. El-Zein, R. A., Fenech, M., Lopez, M. S., Spitz, M. R. and Etzel, C. J. (2008) Cytokinesis-blocked micronucleus cytome assay biomarkers identify lung cancer cases amongst smokers. Cancer Epidemiol. Bio-markers Prev., 17, 1111-1119.
65. Fenech, M. (2002) Chromosomal biomarkers of genomic instability relevant to cancer. Drug Discov. Today, 7, 1128-1137.
66. Fenech, M. and Crott, J. W. (2002) Micronuclei, nucleoplasmic bridges and nuclear buds induced in folic acid deficient human lymphocytes - evidence for breakage-fusion-bridge cycles in the cytokinesis-block micronucleus assay. Mutat. Res., 504, 131-136.
67. Gisselsson, D., Bjork, J., Hoglund, M. et al. (2001) Abnormal nuclear shape in solid tumors reflects mitotic instability. Am. J. Pathol., 158, 199-206.
68. Baskaran, K., Laconi, S. and Reddy, M. K. (1994) Transformation of hamster pancreatic duct cells by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK), in vitro. Carcinogenesis, 15(, 2461-2466. (Pubitemid 24343676)
69. Tithof, P. K., Elgayyar, M., Schuller, H. M., Barnhill, M. and Andrews, R. (2001) 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone, a nicotine derivative, induces apoptosis of endothelial cells. Am. J. Physiol. Heart Circ. Physiol., 281, 1946-1954.
70. Jin, Z., Gao, F., Flagg, T. and Deng, X. (2004) Tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone promotes functional cooperation of Bcl2 and c-Myc through phosphorylation in regulating cell survival and proliferation. J. Biol. Chem., 279, 40209-40219.
71. Wild, C., Vineis, P. and Garte, S. (2008) Molecular Epidemiology of Chronic Diseases. John Wiley & Sons, Ltd, West Sussex, England.
72. Bonassi, S., Znaor, A., Norppa, H. and Hagmar, L. (2004) Chromosomal aberrations and risk of cancer in humans: an epidemiologic perspective. Cytogenet. Genome Res., 104, 376-382.
73. Nordic Study Group on the Health Risk of Chromosome Damage: (1990) An inter-Nordic prospective study on cytogenetic endpoints and cancer risk. Cancer Genet. Cytogenet., 45, 85-92.
74. Boffetta, P., van der Hel, O., Norppa, H. et al. (2007) Chromosomal aberrations and cancer risk: results of a cohort study from Central Europe. Am. J. Epidemiol., 165, 36-43.
75. Bonassi, S., Znaor, A., Ceppi, M. et al. (2007) An increased micronucleus frequency in peripheral blood lymphocytes predicts the risk of cancer in humans. Carcinogenesis, 28, 625-631.
76. Bonassi, S., Norppa, H., Ceppi, M. et al. (2008) Chromosomal aberration frequency in lymphocytes predicts the risk of cancer: results from a pooled cohort study of 22 358 subjects in 11 countries. Carcinogenesis, 29, 1178-1183.
77. Dave, B. J., Hopwood, V. L., Spitz, M. R. and Pathak, S. (1995) Shared cytogenetic abnormalities in lung tumours and corresponding peripheral blood lymphocytes. Int. J. Oncol., 7, 1297-1305.
78. Hagmar, L., Bonassi, S., Strömberg, U., Brøgger, A., Knudsen, L., Norppa, H. and Reuterwall, C. (1998) Chromosomal aberrations in lymphocytes predict human cancer-A report from the European Study Group on Cytogenetic Biomarkers and Health (ESCH). Cancer Res., 58, 4117-4121.
79. Hagmar, L., Strömberg, U., Bonassi, S., Hansteen, I. L., Knudsen, L. E., Lindholm, C. and Norppa, H. (2004) Impact of types of lymphocyte chromosomal aberrations on human cancer risk: results from Nordic and Italian cohorts. Cancer Res., 64(, 2258-2263.
80. Bonassi, S., Abbondandolo, A., Camurri, L. et al. (1995) Are chromosome aberrations in circulating lymphocytes predictive of a future cancer onset in humans? Preliminary results of an Italian cohort study. Cancer Genet. Cytogenet., 79, 133-135.
81. Rossi, A. M., Hansteen, I. L., Skjelbred, C. F. et al. (2009) Association between frequency of chromosomal aberrations and cancer risk is not influenced by genetic polymorphisms in GSTM1 and GSTT1. Environ. Health Perspect., 117, 203-208.
82. Liou, S.-H., Lung, J.-C., Chen, Y.-H., Yang, T., Hsieh, L.-L., Chen, C.-J. and Wu, T.-N. (1999) Increased chromosome-type chromosome aberration frequencies as biomarkers of cancer risk in a blackfoot endemic area. Cancer Res., 59, 1481-1484.
83. Rossner, P., Boffetta, P., Ceppi, M., Bonassi, S., Smerhovsky, Z., Landa, K., Juzova, D. and Srám, R. J. (2005) Chromosomal aberrations in lymphocytes of healthy subjects and risk of cancer. Environ. Health Perspect., 113, 517-520.
84. Bonassi, S., Hagmar, L., Strömberg, U. et al. (2000) Chromosomal aberrations in lymphocytes predict human cancer independently of exposure to carcinogens. European Study Group on Cytogenetic Bio-markers and Health. Cancer Res., 60, 1619-1625.
85. Hagmar, L., Brøgger, A., Hansteen, I.-L. et al. (1994) Cancer risk in humans predicted by increased levels of chromosomal aberrations in lymphocytes: ordic study group on the health risk of chromosomal damage. Cancer Res., 54, 2919-2922.
86. Mitelman, F., Johansson, B. and Mertens, F. (2004) Fusion genes and rearranged genes as a linear function of chromosome aberrations in cancer. Nat. Genet., 36, 331-334.
87. Mitelman, F., Johansson, B. and Mertens, F. (2007) The impact of translocations and gene fusions on cancer causation. Nat. Rev. Cancer, 7, 233-245.
88. Fenech, M. and Bonassi, S. (2010) The effect of age, gender, diet and lifestyle on DNA damage measured using micronucleus frequency in human peripheral blood lymphocytes. Mutagenesis, 26, 43-49.
89. Thomas, P., Wu, J., Dhillon, V. and Fenech, M. (2010) Mutagenesis, 26, 69-76.